KAIST said on Monday that its joint research team identified the overexpression of mt-dsRNAs as a biomarker which can aid treatments of the rare and incurable autoimmune disease, Sjögren's syndrome.Sjögren's syndrome invades exocrine glands such as tear glands and salivary glands. Occular and oral d
Gangnam Severance Hospital said on Monday that it was possible to control long-term convulsions and improve cognitive development in Lennox-Gastaut syndrome (LGS) patients after sequentially applying various therapies.LGS is an intractable epilepsy with various causes of brain structural abnormaliti
The Korea Research Institute of Bioscience and Biotechnology (KRIBB) said on Thursday that they successfully developed a nano-biomaterial that can simultaneously perform precise diagnosis and photothermal therapy (PTT) of cancer cells.Cancer usually has no symptoms until it progresses considerably,
At the CEO session of the World Bio Summit (WBS 2022) in Seoul on Wednesday, both Biovac CEO Dr. Morena Makhoana and Afrigen Biologics and Vaccines Managing Director Petro Terblanche were present.In an interview with Korea Biomedical Review, they shared how they were working closely with the World H
“People talk about ‘three-minute treatments’ in medical fields. However, in reality, a one-minute treatment is not easy. Therefore, saving time in the medical field is becoming increasingly important. I expect our medical artificial intelligence (AI) solution to help make medical fields more efficie
Yonsei University Severance Hospital said on Tuesday that its researchers applied liquid biopsy circulating tumor DNA (ctDNA) tests to predict the prognosis of hepatocellular carcinoma (HCC) patients and observe post-cancer treatment reactions like immunotherapy.Liver cancer is an incurable disease
Dx&Vx said it is participating in overseas research led by Coree Group on finding new biomarkers to develop therapeutics for diabetes and obesity.To search for biomarkers, Agostino Gemelli University Policlinic, an Italy-based hospital, and Coree Group are conducting a clinical study, named, "Compar
A joint team consisting of researchers from Korea University’s College of Medicine (KUCM) and the Institute of Basic Science (IBS) confirmed that a single sequence mutation in the CYFIP2 gene could cause West syndrome, a rare brain development disease.West syndrome occurs in less than six babies per
Lotte Biologics said it decided to turn to rights issues to raise 240.5 billion won ($170.2 million) to finance the acquisition of Bristol-Myers Squibb (BMS)'s Syracuse plant in the U.S and secure operating funds.Lotte Biologics, a biopharmaceutical arm under retail giant Lotte Group, plans to issue
Chong Kun Dang Pharmaceutical said Thursday it received approval for LucenBS (ingredient: ranibizumab), a biosimilar referencing Lucentis to treat wet age-related macular degeneration (AMD), from the Ministry of Food and Drug Safety.LucenBS has secured all five indications of Lucentis -- neovascular
Samsung Biologics said it signed a contract manufacturing organization (CMO) agreement worth 420 billion won ($296 million) with GlaxoSmithKline (GSK).The contract period is from Oct. 11, 2022 to Dec. 31, 2030.However, Samsung Biologics refused to disclose which drug the deal covers, as requested by
Helixmith said on Thursday that it has acquired a Russian patent for a next-generation gene therapy candidate, pMUN+VM202, to treat neuropathic pain.The investigational neuropathic pain treatment combines insulin-like growth factor (IGF-1) and hepatocyte growth factor (HGF) genes. Accordingly, pMUN
Celltrion said it signed a contract with Pinot Bio, a local bioventure, and obtained the option to implement PINOT-ADC, the latter’s antibody-drug conjugate (ADC) linker-payload platform technology.Under the agreement, Celltrion paid an upfront of 1 billion won ($701,754) and secured the right to us
3billion, a company specializing in genetic diagnostics for rare diseases, said on Tuesday that it will reveal its research results at the annual American Society of Human Genetics (ASHG) conference in Los Angeles, the U.S., from Oct. 24-28.The ASHG annual conference is the world's largest conferenc
A multinational research team including Professor Bae Hee-joon of Seoul National University Bundang Hospital (SNUBH) found that ancestry specific stroke genetic risk factors strongly predicted ischemic stroke in European, East Asian and African ancestry.Genome-wide association studies (GWASs) identi
Vaccine hesitancy is a global issue but particularly immunization among pregnant women is a controversial issue because of myths regarding vaccination safety for the mother and baby.As new bivalent Covid-19 vaccines are rolling out again nationwide, mothers should be equipped with the latest knowled
Seoul National University Bundang Hospital (SNUBH) said on Wednesday its team of researchers successfully built a renal hypoxic-reperfusion (RHR) injury model and found that combinational vitamin therapy can decrease the chances of RHR injury.Acute renal injury, which weakens kidney function due to
AriBio said Tuesday that it has filed an IND (investigational new drug) application with the U.S. Food and Drug Administration for a phase 3 clinical trial of its oral dementia treatment, AR1001.AriBio added that it is developing AR1001 as a multi-effect dementia treatment that suppresses dementia p
HK Inno.N said on Wednesday that its gastroesophageal reflux drug, K-CAB (ingredient: tegoprazan) obtained approval from the Indonesian National Agency of Drug and Food Control (NADFC) on Oct. 7, following approvals in Mongolia, China, and the Philippines.K-CAB, Korea's 30th novel drug, is a new pot
Baxter Korea said on Tuesday that it appointed Im Kwang-hyuk, former senior director of Baxter Korea’s Renal and Acute Business unit, as its new general manager, starting Oct. 1.Im joined Baxter’s Renal and Acute Business unit in 2018 and was in charge of peritoneal dialysis and hemodialysis. He was